Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.3 HKD | -1.89% | -8.98% | +11.48% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
Sales 2024 * | 677M 93.43M 730M | Sales 2025 * | 1.5B 207M 1.62B | Capitalization | 6.92B 956M 7.46B |
---|---|---|---|---|---|
Net income 2024 * | -646M -89.21M -697M | Net income 2025 * | -160M -22.1M -173M | EV / Sales 2024 * | 8.9 x |
Net cash position 2024 * | 901M 124M 971M | Net cash position 2025 * | 336M 46.41M 362M | EV / Sales 2025 * | 4.39 x |
P/E ratio 2024 * |
-10.6
x | P/E ratio 2025 * |
-42.9
x | Employees | 432 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.97% |
Latest transcript on Everest Medicines Limited
1 day | -1.89% | ||
1 week | -8.98% | ||
Current month | -4.70% | ||
1 month | -0.21% | ||
3 months | +14.22% | ||
6 months | -10.38% | ||
Current year | +11.48% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Qing Luo
CEO | Chief Executive Officer | 54 | 22-09-18 |
Ian Ying Woo
PSD | President | 51 | 18-11-30 |
Michael Berry
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Fan Li
BRD | Director/Board Member | 55 | 20-08-31 |
Honggang Feng
BRD | Director/Board Member | 59 | Feb. 08 |
Wei Fu
CHM | Chairman | 42 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.75% | 4 M€ | -27.92% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +3.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 23.3 | -1.89% | 2,426,547 |
24-05-22 | 23.75 | +3.71% | 4,413,129 |
24-05-21 | 22.9 | -2.55% | 2,284,000 |
24-05-20 | 23.5 | +0.64% | 2,764,000 |
24-05-17 | 23.35 | -4.11% | 5,464,500 |
Delayed Quote Hong Kong S.E., May 23, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.48% | 975M | |
-1.62% | 89.22B | |
+1.32% | 40.49B | |
-15.73% | 32.79B | |
+64.13% | 26.23B | |
-21.28% | 14.52B | |
-8.50% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- 1952 Stock